Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España
Rafael Ruiz-Montero; David Epstein; Bernardo Guzmán Herrador; Jaime Espín Balbino;
Gac Sanit. 2020;34:318-25
Evaluation of new medicines in Spain and comparison with other European countries
David Epstein; Jaime Espín;
Gac Sanit. 2020;34:133-40
Reform of economic evaluation of medicines in Spain: proposals from the Advisory Committee for Pharmaceutical Financing
Marta Trapero-Bertran; Jaume Puig-Junoy; Emilio J. Alegre-del-Rey; Ana Clopés; Félix Lobo; Ana Ortega;
10.1016/j.gaceta.2024.102439